Needham Maintains Buy on Onto Innovation, Raises Price Target to $92
Needham analyst Quinn Bolton maintains Onto Innovation (NYSE:ONTO) with a Buy and raises the price target from $75 to $92.
Onto Innovation Q4 EPS $1.57 Beats $1.34 Estimate, Sales $253.27M Beat $252.80M Estimate
Onto Innovation (NYSE:ONTO) reported quarterly earnings of $1.57 per share which beat the analyst consensus estimate of $1.34 by 17.16 percent. This is a 27.64 percent increase over earnings of $1.23 per share from the
Earnings Scheduled For February 9, 2023
Companies Reporting Before The Bell
• AstraZeneca (NASDAQ:AZN) is expected to report quarterly earnings at $0.67 per share on revenue of $11.21 billion.
Needham Maintains Buy on Onto Innovation, Raises Price Target to $75
Needham analyst Quinn Bolton maintains Onto Innovation (NYSE:ONTO) with a Buy and raises the price target from $72 to $75.
Earnings Scheduled For October 27, 2022
Companies Reporting Before The Bell
• Janus Henderson Gr (NYSE:JHG) is expected to report quarterly earnings at $0.48 per share on revenue of $494.27 million.
Micron Technology, Novavax, CarGurus And Some Other Big Losers From Tuesday
U.S. stocks closed lower, with the Nasdaq dropping 150 points on Tuesday. Here is the list of some big stocks moving lower in the previous session.
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
Gainers
AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.
Earnings Scheduled For August 9, 2022
Companies Reporting Before The Bell
• Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.
B. Riley Securities Maintains Buy on Onto Innovation, Lowers Price Target to $105
B. Riley Securities analyst Craig Ellis maintains Onto Innovation (NYSE:ONTO) with a Buy and lowers the price target from $115 to $105.